Spatiotemporal analysis of tumor uptake patterns in dynamic ¹⁸FDG-PET and dynamic contrast enhanced CT

References

• Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007;99:1441–54.
   PubMed Web of Science ®Google Scholar
• Glunde K, Pathak AP, Bhujwalla ZM. Molecular-functional imaging of cancer: To image and imagine. Trends Mol Med 2007;13:287–97.
   PubMed Web of Science ®Google Scholar
• Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903–21.
   PubMed Web of Science ®Google Scholar
• Sovik A, Malinen E, Olsen DR. Strategies for biologic image-guided dose escalation: A review. Int J Radiat Oncol Biol Phys 2009;73:650–8.
   PubMed Web of Science ®Google Scholar
• Sovik A, Malinen E, Olsen DR. Adapting biological feedback in radiotherapy. Semin Radiat Oncol 2010;20:138–46.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Alber M. Implementation of hypoxia imaging into treatment planning and delivery. Radiother Oncol 2010; 97:172–5.
   PubMed Web of Science ®Google Scholar
• Grau C, Olsen DR, Overgaard J, Hoyer M, Lindegaard JC, Muren LP. Biology-guided adaptive radiation therapy – presence or future? Acta Oncol 2010;49:884–7.
   PubMed Web of Science ®Google Scholar
• Lee TY, Purdie TG, Stewart, E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171–87.
   PubMedGoogle Scholar
• Castell F, Cook GJ. Quantitative techniques in 18FDG PET scanning in oncology. Br J Cancer 2008;98:1597–601.
   PubMed Web of Science ®Google Scholar
• Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, . Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 2005;46:675–82.
   PubMed Web of Science ®Google Scholar
• Abramyuk A, Wolf G, Shakirin G, Haberland U, Tokalov S, Koch A, . Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors. Acta Radiol 2010;51:793–9.
   PubMed Web of Science ®Google Scholar
• Rodal J, Sovik S, Skogmo HK, Knudtsen IS, Malinen E. Feasibility of contrast-enhanced cone-beam CT for target localization and treatment monitoring. Radiother Oncol 2010;97:521–4.
   PubMed Web of Science ®Google Scholar
• Sovik A. Rodal J, Skogmo HK, Lervag C, Eilertsen K, Malinen, E. Adaptive radiotherapy based on contrast enhanced cone beam CT imaging. Acta Oncol 2010;49:972–7.
   PubMed Web of Science ®Google Scholar
• Mullani NA, Herbst RS, O'Neil RG, Gould KL, Barron BJ, Abbruzzese JL. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: A comparison with 15O-labeled water-measured blood flow. J Nucl Med 2008; 49:517–23.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32.
   PubMed Web of Science ®Google Scholar
• Cao M, Liang Y, Shen C, Miller KD, Stantz, KM. Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype. IEEE Trans Med Imaging 2009;28:861–71.
   PubMed Web of Science ®Google Scholar
• Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad, T. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010;49:354–60.
   PubMed Web of Science ®Google Scholar
• Rodal J, Sovik A, Malinen E. Influence of MLC leaf width on biologically adapted IMRT plans. Acta Oncol 2010;49: 1116–23.
   PubMed Web of Science ®Google Scholar
• Petit SF, Dekker AL, Seigneuric R, Murrer L, van Riel NA, Nordsmark M, . Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: A modelling study. Phys Med Biol 2009;54:2179–96.
   PubMed Web of Science ®Google Scholar
• Konerding MA, Fait E, Gaumann A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 2001;84:1354–62.
   PubMed Web of Science ®Google Scholar
• Paoloni M, Khanna, C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008;8:147–56.
   PubMed Web of Science ®Google Scholar
• Sovik A, Kippenes Skogmo H, Bruland OS, Rune Olsen D, Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 2008;47:1249–56.
   PubMed Web of Science ®Google Scholar
• Sovik S, Skogmo HK, Andersen EK, Bruland OS, Olsen DR, Malinen, E. DCEMRI of spontaneous canine tumors during fractionated radiotherapy: A pharmacokinetic analysis. Radiother Oncol 2009;93:618–24.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, . Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766–73.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Nielsen T, Ostergaard L, Overgaard J. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response. Acta Oncol 2006;45:876–80.
   PubMed Web of Science ®Google Scholar
• Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, . Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759–67.
   PubMed Web of Science ®Google Scholar
• Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–6.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007;8:63–74.
   PubMed Web of Science ®Google Scholar
• Newbold K, Castellano I, Charles-Edwards E, Mears D, Sohaib A, Leach M, . An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74:29–37.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Egeland TA, Gulliksrud K, Gaustad JV, Mathiesen, B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838–45.
   PubMed Web of Science ®Google Scholar
• Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: A survey of image segmentation techniques. Eur J Nucl Med Mol Imaging 2010;37:2165–87.
   PubMed Web of Science ®Google Scholar